Benzinga | Nov 9, 2020 07:19AM EST

Neos Therapeutics Q3 EPS $(0.10) Misses $(0.05) Estimate, Sales $12.54M Miss $15.47M Estimate

Neos Therapeutics (NASDAQ:NEOS) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.05) by 100 percent. This is a 150 percent decrease over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $12.54 million which missed the analyst consensus estimate of $15.47 million by 18.97 percent. This is a 28.53 percent decrease over sales of $17.54 million the same period last year.